HERZUMA

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug HERZUMA contains one active pharmaceutical ingredient (API):

1 Trastuzumab UNII P188ANX8CK - TRASTUZUMAB

Trastuzumab is a recombinant humanised IgG1 monoclonal antibody against the human epidermal growth factor receptor 2 (HER2). Τrastuzumab has been shown, in both in vitro assays and in animals, to inhibit the proliferation of human tumour cells that overexpress HER2. Read about Trastuzumab

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01FD01	Trastuzumab	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FD HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
Discover more medicines within L01FD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10383L, 10391X, 10401K, 10402L, 10581X, 10588G, 10589H, 10597R, 4632T, 4639E, 4650R, 4703M, 7264H, 7265J, 7266K, 7267L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 545120010000207, 545120020000307
Country: CA	Health Products and Food Branch	Identifier(s): 02480794
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 141-MBE-0819, 156-MBE-0520
Country: EE	Ravimiamet	Identifier(s): 1764569, 1790434
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1171257001, 1171257002
Country: FR	Base de données publique des médicaments	Identifier(s): 62425937, 68153262
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 353268, 365903
Country: HK	Department of Health Drug Office	Identifier(s): 66513, 66773
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9337
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1085085, 1086535
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 150975, 57991
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 19077, 19078
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100402037, 100420905
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64586001, W65546001
Country: SG	Health Sciences Authority	Identifier(s): 15838P, 15839P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680614140136
Country: US	FDA, National Drug Code	Identifier(s): 63459-303
Country: ZA	Health Products Regulatory Authority	Identifier(s): 53/26/0598, 53/26/0599